Dr. Muhammad Imran Kafeel, MD

Dr. Kafeel practices at Brooklyn Radiation Oncology in Flushing, New York.

Dr. Kafeel's NPI, 1174756423, was assigned on September 2, 2009. Dr. Kafeel graduated from Santiago Univ of Technology School of Medicine in 1998. Dr. Kafeel's New York license number on file is 252385.

Dr. Kafeel's primary practice is Brooklyn Radiation Oncology, at 158-6 Northern Blvd, Flushing, NY 11358 in Queens County. The practice phone is (718) 517-2900.

Dr. Kafeel's primary practice is Brooklyn Radiation Oncology in Flushing, New York. The medical group on file is Jamaica Hospital Medical Center. Dmand AI also links Dr. Kafeel to 2 more medical groups, 1 physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kafeel practices, 2 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Kafeel's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Kafeel's licenses on file in 2 states: New York and Texas.

Dmand AI lists breast cancer, chronic anemia, colorectal cancer, deep vein thrombosis (DVT), fluid and electrolyte imbalances, lung cancer, lymphoma and multiple myeloma among the conditions Dr. Kafeel treats.

CMS data shows 12,133 Medicare services from Dr. Kafeel across 9 procedure codes in 2024, for 85 Medicare patients. Medicare paid $58,360 for them. Every service was in an office.

CMS counts 85 Medicare patients who saw Dr. Kafeel in 2024. The largest group is 75 to 84, with 33 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 59% are also on Medicaid. Their average risk score is 2.15, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kafeel's median patient age at 53, with 69% women.

In 2024, Dr. Kafeel wrote 1,352 Medicare Part D claims for 137 patients. 69% of them were for generic drugs. CMS names the drug for 984 of them, across 37 drugs with 11 or more claims each, at $1,871,811 in total drug cost. In 2023, CMS named 863 claims across 36 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Kafeel for performance year 2024, reported as part of a group. Dr. Kafeel accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kafeel as offering telehealth.

Dmand AI links 4 papers to Dr. Kafeel, published from 2012 to 2022. Dr. Kafeel's most frequent co-authors are Stephen Marc Lichter, MD, Iqra Arshad, MD and Naga Koteswari Sucha Cheedella, MD.

CMS Open Payments shows 384 general payments to Dr. Kafeel from 53 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 74% of the total. Novartis Pharmaceuticals Corporation paid the most, $2,076.

Dr. Kafeel graduated from Santiago Univ of Technology School of Medicine in 1998.

Dr. Kafeel is in network with 16 carriers, including Aetna, Elevance and United Healthcare. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.